Not the norm of how BP operate. They usually only do license deal with companies close to end of Ph3 as they are close to commercialisation. Why would they want to spend a lot of money funding another company's Ph3 clinical trial???
- Forums
- ASX - By Stock
- Media Thread
Not the norm of how BP operate. They usually only do license...
-
- There are more pages in this discussion • 2,798 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $389.5M |
Open | High | Low | Value | Volume |
5.3¢ | 5.4¢ | 5.2¢ | $384.2K | 7.271M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 1723946 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 905438 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 1723946 | 0.052 |
38 | 4359102 | 0.051 |
48 | 4380509 | 0.050 |
17 | 2263068 | 0.049 |
18 | 930368 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 905438 | 6 |
0.054 | 2937407 | 6 |
0.055 | 987079 | 14 |
0.056 | 2547393 | 9 |
0.057 | 1002553 | 10 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online